Remunity® (treprostinil)

DRUG/DEVICE
Prefilled disposable cassette and durable infusion pump with treprostinil injection, for subcutaneous use
ROUTE OF ADMINISTRATION
Subcutaneous
THERAPEUTIC PLATFORM
Remodulin®
TERRITORY
Worldwide
COMMERCIAL PRODUCT
STATUS
FDA Cleared
(Commercially launched U.S. sales in February 2021)